Latest news
Orion License Partner Tenax's Pulmonary Hypertension Drug Fails to Improve Walk Distance in Late-stage Trial - marketscreener.commarketscreener.com · Mon, 10 Aug 2026 13:36:28 GMTOrion Oyj - Via RitzauVia Ritzau · Mon, 10 Aug 2026 11:05:00 GMTFRA:OFKB Cyclically Adjusted Price-to-FCF: 48.61 — 85% Abo - GuruFocusGuruFocus · Sun, 09 Aug 2026 19:35:26 GMTORION CORPORATION ADR, each representing 0.5 Class B shares (ORINY.US), will release its earnings report before market open on July 17. - MoomooMoomoo · Mon, 03 Aug 2026 00:43:34 GMTIs Orion Oyj (HLSE:ORNBV) Undervalued Following Strong Earnings And Higher 2026 Guidance? - simplywall.stsimplywall.st · Wed, 29 Jul 2026 09:27:17 GMT